A Counselling Model for BRCA1/2 Genetic Susceptibility Testing

Hereditary Cancer in Clinical Practice

Volumn 2, Issue 1, 2004, Pages

  van Oostrom, Iris ^a   Tibben, Aad ^b  

^a Department of Medical Psychology and Psychotherapy ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genetic Counselling; Genetic Testing; Mutation Carrier; Psychological Distress; Psychological Impact

Indexed keywords

BLOOD SAMPLING; CONTROLLED STUDY; DRUG ANALYSIS; EMOTIONAL STRESS; ETIOLOGY; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; PROTOCOL; REVIEW;

EID: 33751394874     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-2-1-19     Document Type: Review

References (28)

1. D.F. Easton D. Ford D.T. Bishop Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Am J Hum Genet 1995 56 1 265 271 1801337 1:STN:280:DyaK2M7is1Whsw%3D%3D 7825587
2. D. Ford D.F. Easton M. Stratton S. Narod D. Goldgar P. Devilee D.T. Bishop B. Weber G. Lenoir J. Chang-Claude H. Sobol M.D. Teare J. Struewing A. Arason S. Scherneck J. Peto T.R. Rebbeck P. Tonin S. Neuhausen R. Barkardottir J. Eyfjord H. Lynch B.A. Ponder S.A. Gayther J.M. Birch A. Lindblom D. Stoppa-Lyonnet Y. Bignon A. Borg U. Hamann N. Haites R.J. Scott C.M. Maugard H. Vasen S. Seitz L.A. Cannon-Albright A. Schofield M. Zelada-Hedman Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 1998 62 3 676 689 1376944 10.1086/301749 1:CAS:528:DyaK1MXlvFeh 9497246
3. A. Antoniou P.D. Pharoah S. Narod H.A. Risch J.E. Eyfjord J.L. Hopper N. Loman H. Olsson O. Johannsson A. Borg B. Pasini P. Radice S. Manoukian D.M. Eccles N. Tang E. Olah H. Anton-Culver E. Warner J. Lubinski J. Gronwald B. Gorski H. Tulinius S. Thorlacius H. Eerola H. Nevanlinna K. Syrjakoski O.P. Kallioniemi D. Thompson C. Evans J. Peto F. Lalloo D.G. Evans D.F. Easton Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies Am J Hum Genet 2003 72 5 1117 1130 1180265 10.1086/375033 1:CAS:528:DC%2BD3sXjslagtbg%3D 12677558
4. M. Horowitz E. Sundin A. Zanko R. Lauer Coping with grim news from genetic tests Psychosomatics 2001 42 2 100 105 10.1176/appi.psy.42.2.100 1:STN:280:DC%2BD3MzotFKlsQ%3D%3D 11239121
5. L.N. Lodder P.G. Frets R.W. Trijsburg E.J. Meijers-Heijboer J.G. Klijn H.J. Duivenvoorden A. Tibben A. Wagner C.D. Meer CAvan der P. Devilee C.J. Cornelisse M.F. Niermeijer Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? J Med Genet 1999 36 12 906 913 1734277 1:STN:280:DC%2BD3c%2FmtlSjsQ%3D%3D 10593998
6. C. Lerman S. Narod K. Schulman C. Hughes A. Gomez-Caminero G. Bonney K. Gold B. Trock D. Main J. Lynch C. Fulmore C. Snyder S.J. Lemon T. Conway P. Tonin G. Lenoir H. Lynch RCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes JAMA 1996 275 1885 1892 10.1001/jama.1996.03530480027036 1:STN:280:DyaK283ls1ensA%3D%3D 8648868
7. R.T. Croyle K.R. Smith J.R. Botkin B. Baty J. Nash Psychological response to BRCA1 mutation testing: preliminary findings Health Psychol 1997 16 63 72 10.1037/0278-6133.16.1.63 1:STN:280:DyaK2s7otVKnsg%3D%3D 9028816
8. L. Lodder P.G. Frets R.W. Trijsburg E.J. Meijers-Heijboer J.G. Klijn H.J. Duivenvoorden A. Tibben A. Wagner C.D. Meer CAvan der A.D. Ouweland AMvan den M.F. Niermeijer Psychological impact of receiving a BRCA1/BRCA2 test result Am J Med Genet 2001 98 15 24 10.1002/1096-8628(20010101)98:1<15::AID-AJMG1014>3.0.CO;2-0 1:STN:280:DC%2BD3MzmsFClsw%3D%3D 11426450
9. M.D. Schwartz B.N. Peshkin C. Hughes D. Main C. Isaacs C. Lerman Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample J Clin Oncol 2002 20 2 514 520 10.1200/JCO.20.2.514 11786581
10. L.N. Lodder P.G. Frets R.W. Trijsburg E.J. Meijers-Heijboer J.G. Klijn C. Seynaeve A.N. van Geel M.M. Tilanus C.C. Bartels L.C. Verhoog C.T. Brekelmans C.W. Burger M.F. Niermeijer One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery) Breast Cancer Res Treat 2002 73 2 97 112 10.1023/A:1015269620265 1:CAS:528:DC%2BD38XksFehtrw%3D 12088120
11. B. Meiser P. Butow M. Friedlander A. Barratt V. Schnieden M. Watson J. Brown K. Tucker Psychological impact of genetic testing in women from high-risk breast cancer families Eur J Cancer 2002 38 15 2025 2031 10.1016/S0959-8049(02)00264-2 1:STN:280:DC%2BD38nhvFWgtQ%3D%3D 12376208
12. I. Van Oostrom H. Meijers-Heijboer L.N. Lodder H.J. Duivenvoorden A.R. van Gool C. Seynaeve C.D. Meer CAvan der J.G. Klijn B.N. van Geel C.W. Burger J.W. Wladimiroff A. Tibben Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study J Clin Oncol 2003 21 20 3867 3874 10.1200/JCO.2003.10.100 14551306
13. M.E. Wood L. Mullineaux A.K. Rahm D. Fairclough L. Wenzel Impact of BRCA1 testing on women with cancer: a pilot study Genet Test 2000 4 3 265 272 10.1089/10906570050501489 1:STN:280:DC%2BD3M%2FpsFOgug%3D%3D 11142757
14. J.C. Coyne L. Kruus M. Racioppo K.A. Calzone K. Armstrong What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer? Am J Med Genet 2003 116 3 222 228 10.1002/ajmg.a.10844
15. C. Foster D.G. Evans R. Eeles D. Eccles S. Ashley L. Brooks R. Davidson J. Mackay P.J. Morrison M. Watson Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort Br J Cancer 2002 86 8 1209 1216 2375339 10.1038/sj.bjc.6600253 1:STN:280:DC%2BD383hs1KmtA%3D%3D 11953874
16. J.C. Coyne N.R. Benazon C.G. Gaba K. Calzone B.L. Weber Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families J Consult Clin Psychol 2000 68 864 874 10.1037/0022-006X.68.5.864 1:STN:280:DC%2BD3crhtFOitQ%3D%3D 11068972
17. P. Hopwood F. Keeling A. Long C. Pool G. Evans A. Howell Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators Psychooncology 1998 7 5 402 412 10.1002/(SICI)1099-1611(1998090)7:5<402::AID-PON317>3.0.CO;2-X 1:STN:280:DyaK1M%2Fis1ymuw%3D%3D 9809331
18. J. Audrain M.D. Schwartz C. Lerman C. Hughes B.N. Peshkin B. Biesecker Psychological distress in women seeking genetic counselling for breast-ovarian cancer risk: the contributions of personality and appraisal Ann Behav Med 1997 19 4 370 377 10.1007/BF02895156 1:STN:280:DyaK1czntFKmsQ%3D%3D 9706364
19. J.C. Coyne K.K. Anderson Marital status, marital satisfaction, and support processes among women at high risk for breast cancer J Fam Psychol 1999 13 629 641 10.1037/0893-3200.13.4.629
20. J.E. Wylie K.R. Smith J.R. Botkin Effects of spouses on distress experienced by BRCA1 mutation carriers over time Am J Med Genet 2003 119C 1 35 44 10.1002/ajmg.c.10002 12704636
21. K.R. Smith J.A. West R.T. Croyle J.R. Botkin Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing Cancer Epidemiol Biomarkers Prev 1999 8 385 392 1:STN:280:DyaK1M3isVSmsw%3D%3D 10207644
22. M. Dorval A.F. Patenaude K.A. Schneider S.A. Kieffer L. DiGianni K.J. Kalkbrenner J.I. Bromberg L.A. Basili K. Calzone J. Stopfer B.L. Weber J.E. Garber Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs J Clin Oncol 2000 18 2135 2142 1:STN:280:DC%2BD3c3nt1SjsQ%3D%3D 10811679
23. K.P. Tercyak C. Lerman B.N. Peshkin C. Hughes D. Main C. Isaacs M.D. Schwartz Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counselling and testing for breast and ovarian cancer risk Health Psychol 2001 20 3 217 222 10.1037/0278-6133.20.3.217 1:STN:280:DC%2BD3MzjsFyjsw%3D%3D 11403219
24. C. Lerman C. Hughes S.J. Lemon D. Main C. Snyder C. Durham S. Narod H.T. Lynch What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing J Clin Oncol 1998 16 1650 1654 1:STN:280:DyaK1c3ks1artA%3D%3D 9586874
25. L. Lodder P.G. Frets R.W. Trijsburg J.G. Klijn C. Seynaeve M.M. Tilanus C.C. Bartels E.J. Meijers-Heijboer L.C. Verhoog M.F. Niermeijer Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing Am J Med Genet 2003 119A 3 266 272 10.1002/ajmg.a.10168 12784290
26. K. Brain J. Soldan J. Sampson J. Gray Genetic counselling protocols for hereditary non-polyposis colorectal cancer: a survey of UK regional genetics centres Clin Genet 2003 63 3 198 204 10.1034/j.1399-0004.2003.00039.x 1:STN:280:DC%2BD3s7ns1eqsw%3D%3D 12694229
27. K. Aktan-Collan J.P. Mecklin A. de la Chapelle P. Peltomaki A. Uutela H. Kaariainen Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer J Med Genet 2000 37 2 108 113 1734517 10.1136/jmg.37.2.108 1:STN:280:DC%2BD3c7jtVegtA%3D%3D 10662810
28. C. Julian-Reynier M. Welkenhuysen L. Hagoel M. Decruyenaere P. Hopwood CRISCOM Working Group Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services Eur J Hum Genet 2003 11 10 725 736 10.1038/sj.ejhg.5201037 14512961